NCT00980460 2026-03-19
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT05027425 2024-11-22
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Active not recruiting
NCT04898504 2024-11-07
EXCALIBUR1+2
Oslo University Hospital
Phase 2 Active not recruiting
NCT02597348 2024-02-14
TRANSMET
Assistance Publique - Hôpitaux de Paris
Phase NA Active not recruiting